Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Beyond Static Subtypes in Large B-cell Lymphoma: Context, Plasticity, and Therapeutic Logic.
Journal: Blood cancer discovery
Published: June 02, 2026
Knockdown of the long isoform of the prolactin receptor selectively targets pathogenic immune cells in systemic lupus erythematosus and averts glomerular pathology.
Journal: bioRxiv : the preprint server for biology
Published: March 27, 2026
PD-1 expression identifies proliferating malignant CLL B cells and is a potential biomarker of response to BTK inhibitor therapy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 04, 2025
Multi-Institutional Study of ALK-Positive Large B-Cell Lymphoma: Outcomes in the Era of ALK Inhibitors and Biologically Informed Therapies.
Journal: American journal of hematology
Published: June 20, 2025
Plasma Cytokine and Chemokine Profiles Predict Efficacy and Toxicity of Anti-CD19 CAR-T Cell Therapy in Large B-Cell Lymphoma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 24, 2024
Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort Study.
Journal: American journal of hematology
Published: October 01, 2024
Addressing Health Disparities in Hematologic Malignancies: from Genes to Outreach.
Journal: Blood cancer discovery
Published: July 11, 2024
Real-World Effectiveness of Chemoimmunotherapy and Novel Therapies for Patients With Relapsed/Refractory Aggressive Large B-Cell Lymphoma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: June 13, 2024
T Cells Spatially Regulate B Cell Receptor Signaling in Lymphomas through H3K9me3 Modifications.
Journal: Advanced healthcare materials
Published: March 29, 2024
Last Updated: 09/26/2026